Philip Ferneau - 18 Feb 2022 Form 4 Insider Report for Compass Therapeutics, Inc. (CMPX)

Role
Director
Signature
/s/ Vered Bisker-Leib, attorney-in-fact
Issuer symbol
CMPX
Transactions as of
18 Feb 2022
Net transactions value
$0
Form type
4
Filing time
23 Feb 2022, 16:45:34 UTC
Next filing
09 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMPX Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 18 Feb 2022 Common Stock 30,000 $2.40 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in substantially equal monthly installments over four years.
F2 The Reporting Person is a managing partner of Borealis Ventures. Pursuant to an agreement with Borealis Ventures, the Reporting Person is obligated to transfer any securities issued under any stock options or other awards, or the economic benefit thereof, to Borealis Granite Fund, L.P. and Vox Health Fund, L.P.

Remarks:

Exhibit 24 - Power of Attorney